miR-200c sensitizes breast cancer cells to doxorubicin treatment by decreasing TrkB and Bmi1 expression.

Cited by papers we hold 3

• The miR-200 Family of microRNAs: Fine Tuners of Epithelial-Mesenchymal Transition and Circulating Cancer Biomarkers · 2021
  No notice
• The role and mechanisms of action of microRNAs in cancer drug resistance · 2019
  No notice
• The microRNA-200 family: small molecules with novel roles in cancer development, progression and therapy · 2015
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.